158 related articles for article (PubMed ID: 38084140)
1. Inhibition of hepatocellular carcinoma growth
Li S; Cai X; Chen L; Lin M; Zhu Z; Xiao H; Nie P; Chen Q; Yang X
PeerJ; 2023; 11():e16593. PubMed ID: 38084140
[TBL] [Abstract][Full Text] [Related]
2. Berberine activates PPARδ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma.
Shou JW; Shaw PC
Phytomedicine; 2023 Jul; 115():154842. PubMed ID: 37148713
[TBL] [Abstract][Full Text] [Related]
3. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
Liu Z; Chen JY; Zhong Y; Xie L; Li JS
Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
[TBL] [Abstract][Full Text] [Related]
4. Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death.
Wang K; Zhang C; Bao J; Jia X; Liang Y; Wang X; Chen M; Su H; Li P; Wan JB; He C
Sci Rep; 2016 Jun; 6():26064. PubMed ID: 27263652
[TBL] [Abstract][Full Text] [Related]
5. Berberine Represses
Vishnoi K; Ke R; Saini KS; Viswakarma N; Nair RS; Das S; Chen Z; Rana A; Rana B
Mol Pharmacol; 2021 Jan; 99(1):1-16. PubMed ID: 33130557
[TBL] [Abstract][Full Text] [Related]
6. A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis.
Zhao JA; Nie W; Dong L; Liu W; Wei W
J Gastroenterol Hepatol; 2021 Oct; 36(10):2967-2977. PubMed ID: 33982329
[TBL] [Abstract][Full Text] [Related]
7. Berberine enhances the radiosensitivity of hepatoma cells by Nrf2 pathway.
You X; Cao X; Lin Y
Front Biosci (Landmark Ed); 2019 Jun; 24(7):1190-1202. PubMed ID: 31136975
[TBL] [Abstract][Full Text] [Related]
8. Curcumin restrains hepatocellular carcinoma progression depending on the regulation of the circ_0078710/miR-378b/PRIM2 axis.
Chen Q; Guo H; Zong Y; Zhao X
J Recept Signal Transduct Res; 2022 Jun; 42(3):313-324. PubMed ID: 34139933
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells.
Abdallah FM; Helmy MW; Katary MA; Ghoneim AI
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1399-1410. PubMed ID: 30155693
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of MiR-34 Family and DNA Methyltransferases 1, 3A, 3B Gene Expression Levels in Hepatocellular Carcinoma Following Treatment with Dendrosomal Nanocurcumin.
Chamani F; Sadeghizadeh M; Masoumi M; Babashah S
Asian Pac J Cancer Prev; 2016; 17(S3):219-24. PubMed ID: 27165229
[TBL] [Abstract][Full Text] [Related]
11. LINC01605 regulates proliferation, migration and invasion of colorectal cancer cells via targeting miR-3960/SOX11.
Hu SS; Fu L; Han SY; Li XL; Zhang LD
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1322-1329. PubMed ID: 33629302
[TBL] [Abstract][Full Text] [Related]
12. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF
Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y
Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379
[TBL] [Abstract][Full Text] [Related]
13. Berberine inhibits the development of endometrial cancer through circ_ZNF608/miR-377-3p/COX2 axis.
Liang H; Liu Y; Fu L; Li L; Gong N
Autoimmunity; 2022 Nov; 55(7):485-495. PubMed ID: 35876160
[TBL] [Abstract][Full Text] [Related]
14. Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation.
Song L; Luo Y; Wang X; Almutairi MM; Pan H; Li W; Liu Y; Wang Q; Hong M
Mol Med Rep; 2019 Nov; 20(5):4654-4664. PubMed ID: 31545468
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
[TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR‑429.
Gu Y; Zhou Z
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846796
[TBL] [Abstract][Full Text] [Related]
17. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.
Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W
J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits proliferation of hepatocellular carcinoma cells through down regulation of DJ-1.
Han L; Wang Y; Sun S
Cancer Biomark; 2020; 29(1):1-8. PubMed ID: 32417759
[TBL] [Abstract][Full Text] [Related]
19. E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription.
Hao F; Wang N; Zhang Y; Xu W; Chen Y; Fei X; Wang J
Mol Carcinog; 2022 Nov; 61(11):975-988. PubMed ID: 35924788
[TBL] [Abstract][Full Text] [Related]
20. Effect of Curcumin in Comparison with Trichostatin A on the Reactivation of Estrogen Receptor Alpha gene Expression, Cell Growth Inhibition and Apoptosis Induction in Hepatocellular Carcinoma Hepa 1-6 Cell lLine.
Sanaei M; Kavoosi F; Arabloo M
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1045-1050. PubMed ID: 32334468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]